Company profile for Propanc Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading thr...
Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
302/6 Butler Street Camberwell, VIC 3124
Telephone
Telephone
+61 (0)3 9882 0780
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3197031/0/en/Propanc-Biopharma-Requests-Foreign-Filing-License-from-Spain-for-Methods-of-Treating-Resistant-Cancer-and-Fibrosis.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/17/3189180/0/en/Propanc-Biopharma-Provides-Corporate-Update-and-Reports-First-Quarter-2025-26-Results.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184607/0/en/Propanc-Biopharma-Inc-Secures-up-to-100-Million-Private-Placement-to-Support-Digital-Asset-Acquisition-Strategy-Accelerate-Company-s-R-D-Pipeline.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/15/3167562/0/en/CORRECTION-Propanc-Biopharma-Announces-Strategic-Financing-Agreement-of-up-to-100-Million-with-Hexstone-Capital.html

GLOBENEWSWIRE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/10/07/3162521/0/en/Propanc-Reports-End-of-Fiscal-Year-Highlights-and-Outlines-Therapeutic-Development-100M-Digital-Asset-Treasury-Strategy.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/09/17/3151648/0/en/Propanc-Biopharma-Receives-Certificate-of-Grant-for-Proenzyme-Composition-Patent-from-US-Patent-Trademark-Office.html

GLOBENEWSWIRE
17 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty